Kusajili – Clinical trials directory

Result of your search per sponsor: Pfizer Inc. - La Jolla laboratories

Woman and Man Max 99 years
Pfizer Inc. - La Jolla laboratories Update Il y a 4 ans

A randomized phase 2 study of the anti-angiogenesis agent AG-013736 in combination with gemcitabine in patients with chemotherapy-naïve advanced pancreatic cancer preceded by a phase 1 portion Determine whether the overall survival of the combination of AG-013736 and gemcitabine is superior to that of gemcitabine alone in patients who have advanced pancreatic cancer that has not been previo...

Country None
organs None
Specialty None

Closed trial

More information